Producer
Bio-Rad Laboratories
Life science research and diagnostics company (NYSE: BIO); Hercules, California; manufactures RNA purification kits and real-time PCR reagents; known for ddPCR (digital droplet PCR) technology; 5-8% of DNA/RNA extraction market; important supplier for research and smaller diagnostic labs; does not have Qiagen's scale in clinical viral RNA extraction
1
Inputs supplied
1
Goods downstream
0
Facilities
0
Stories
What they make
1 input Bio-Rad Laboratories supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something Bio-Rad Laboratories makes, pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map, where this supply-chain role fits within their broader business.
Life Science Research (Instruments & Reagents)
55%Clinical Diagnostics (Quality Control)
45%
Intelligence
What's known
Sourced claims about this company's role in supply chains, chokepoints, concentration, incidents, dual-use connections.
Origin2023
Bio-Rad Laboratories was founded in 1952 in Berkeley, California by David and Alice Schwartz, who began by supplying chemicals to the burgeoning Bay Area research community. The company has remained under Schwartz family control for over 70 years -- an unusual governance structure for a NYSE-listed company with $2.8B+ in annual revenue. The family's long-term perspective enabled Bio-Rad to develop and patent ddPCR (Droplet Digital PCR) technology, which partitions a PCR reaction into 20,000 individual oil droplets to enable absolute quantification of DNA or RNA molecules without a standard curve. ddPCR is now the gold standard for detecting low-level viral residual in vaccine manufacturing, rare mutation detection in cancer diagnostics, and copy number variation analysis. A Berkeley family-controlled company's investment in a niche quantitative biology technology became critical quality control infrastructure for mRNA vaccine manufacturing quality assurance during COVID -- Bio-Rad's ddPCR instruments were used to verify plasmid DNA and mRNA purity at Pfizer, Moderna, and contract manufacturers globally.
Bio-Rad Laboratories Inc. ↗